we undertook a prospective double-blind controlled study to compare the efficacy of a drug that usually has no antistaphylococcal activity ( amoxicillin trihydrate ) with the efficacy of the same drug with an addition of a beta-lactamase inhibitor ( amoxicillin plus clavulanic acid [ augmentin ] ) in the treatment of nonbullous impetigo .
C0054066
amoxicillin
C0591132
augmentin